Mechanical valve replacement in congenital heart defects in the era of international normalized ratio self-management

ASAIO Journal

Volumn 51, Issue 5, 2005, Pages 530-532

  Reiss, N ^a,b   Blanz, U ^a   Bairaktaris, H ^a   Koertke, A ^a   Korfer R ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; COAGULATION; DISEASE CONTROL; GRAFTS; HEMODYNAMICS; PATIENT MONITORING;

DURABLE VALVES; HEART DEFECTS; VALVE REPLACEMENT; XENOGRAFTS;

CARDIOLOGY;

ANTICOAGULANT AGENT; PHENPROCOUMON;

ADOLESCENT; ADULT; ANTICOAGULATION; ATRIOVENTRICULAR BLOCK; BLOOD CLOT LYSIS; CALCIFICATION; CHILD; CONFERENCE PAPER; CONGENITAL HEART MALFORMATION; DEGENERATION; EBSTEIN ANOMALY; FALLOT TETRALOGY; FEMALE; FOLLOW UP; GREAT VESSELS TRANSPOSITION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMODYNAMICS; HUMAN; INCIDENCE; INFANT; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PATENT DUCTUS ARTERIOSUS; PERFORMANCE; REOPERATION; SAINT JUDE HEART VALVE PROSTHESIS; SWINE; THROMBOEMBOLISM; TREATMENT OUTCOME; XENOGRAFT;

ADOLESCENT; ADULT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; DICUMAROL; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HUMANS; INFANT; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; REOPERATION; SELF CARE; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 26444502126     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mat.0000176119.56534.90     Document Type: Conference Paper

References (11)

1. Edmunds LH: Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg 44: 430-435, 1987.
2. Butchart EG: Prosthesis-specific and patient-specific anticoagulation, in: Butchart EG, Bodnar E (eds), Thrombosis, Embolism and Bleeding. London, ICR Publishers, 1992, pp. 293-317.
3. Koertke H, Koerfer R: International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 72: 44-40, 2001.
4. Janusz MT, Jamieson WR, Allen P, et al: Experience with the Carpentier-Edwards porcine valve prosthesis in 700 patients. Ann Thorac Surg 34: 625-633, 1982.
5. Arom KV, Nicoloff DM, Kersten TE, et al: St. Jude Medical prosthesis: Valve-related deaths and complications. Ann Thorac Surg 43: 591-598, 1987.
6. Czer LS, Weiss M, Bateman TM, et al: Fibrinolytic therapy of St. Jude valve thrombosis under guidance of digital cinefluoroscopy. J Am Coll Cardiol 5: 1244-1249, 1985.
7. Ilbawi MN, Lockhart CG, Idriss FS, et al: Experience with St. Jude Medical valve prosthesis in children: A word of caution regarding right-sided placement. J Thorac Cardiovasc Surg 93: 73-79, 1987.
8. Miyamura H, Kanazawa H, Hayashi J, Eguchi S: Thrombosed St. Jude Medical valve prosthesis in the right side of the heart in patients with tetralogy of Fallot. J Thorac Cardiovasc Surg 94: 148-150, 1987.
9. Fyfe DA, Taylor AB, Kline CH, et al: Doppler echocardiographic evaluation of streptokinase lysis of thrombosed right-side St. Jude Medical valves in patients with congenital heart defects. Am Heart J 121: 1156-1160, 1991.
10. Rao PS, Solymar L, Mardini MK, et al: Anticoagulant therapy in children with prosthetic valves. Ann Thorac Surg 47: 589-592, 1989.
11. Koertke H, Minami K, Boethig D, et al: INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation 1(108 Suppl): 1175-1178, 2003.